BioAge Labs (BIOA) Current Assets (2023 - 2026)

BioAge Labs has disclosed Current Assets across 4 years of filings, most recently posting $391.9 million for Q1 2026.

• Current Assets for Q1 2026 came in at $391.9 million, up 20.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $391.9 million (up 20.64% YoY), and the FY2025 annual result was $286.8 million, down 19.69% from the prior year.
• Current Assets came in at $391.9 million for Q1 2026 at BioAge Labs, up from $286.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $391.9 million in Q1 2026 to a low of $25.3 million in Q4 2023.
• The 4-year median for Current Assets is $313.3 million (2025), against an average of $289.4 million.
• Across the five-year window, Current Assets surged 1311.14% in 2024 and decreased 19.69% in 2025, its largest moves.
• BioAge Labs' Current Assets stood at $25.3 million in 2023, then soared by 1311.14% to $357.1 million in 2024, then fell by 19.69% to $286.8 million in 2025, then soared by 36.64% to $391.9 million in 2026.
• The last three Current Assets figures came in at $391.9 million (Q1 2026), $286.8 million (Q4 2025), and $290.8 million (Q3 2025), per Business Quant data.